Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Equity: 2020-2025

Historic Return on Equity for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to -0.15%.

  • Mirum Pharmaceuticals' Return on Equity rose 28.00% to -0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.15%, marking a year-over-year increase of 28.00%. This contributed to the annual value of -0.37% for FY2024, which is 47.00% up from last year.
  • Mirum Pharmaceuticals' Return on Equity amounted to -0.15% in Q3 2025, which was up 36.87% from -0.24% recorded in Q2 2025.
  • Mirum Pharmaceuticals' 5-year Return on Equity high stood at -0.15% for Q3 2025, and its period low was -2.35% during Q3 2021.
  • Its 3-year average for Return on Equity is -0.62%, with a median of -0.47% in 2024.
  • In the last 5 years, Mirum Pharmaceuticals' Return on Equity soared by 205bps in 2022 and then slumped by 112bps in 2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Return on Equity (Quarterly) stood at -0.95% in 2021, then climbed by 8bps to -0.87% in 2022, then climbed by 24bps to -0.63% in 2023, then rose by 25bps to -0.38% in 2024, then climbed by 28bps to -0.15% in 2025.
  • Its last three reported values are -0.15% in Q3 2025, -0.24% for Q2 2025, and -0.34% during Q1 2025.